BRIEF-BioNTech Says Pfizer,Co Request Regulatory Agencies Expand Emergency Use Of Their Covid-19 Vaccine To Adolescents

路透社 · Apr 10, 2021 00:58

April 9 (Reuters) - BioNTech SE :
   * PFIZER AND BIONTECH REQUEST REGULATORY AGENCIES EXPAND EMERGENCY USE OF THEIR COVID-19 VACCINE TO ADOLESCENTS
   * REQUESTED AMENDMENTS TO U.S. EUA OF THE PFIZER-BIONTECH VACCINE TO EXPAND USE IN ADOLESCENTS 12 TO 15 YEARS OF AGE
   * REQUESTS BASED ON DATA FROM PIVOTAL PHASE 3 TRIAL IN ADOLESCENTS 12 TO 15 YEARS OF AGE WITH OR WITHOUT PRIOR EVIDENCE OF SARS-COV-2 INFECTION
   * COMPANIES PLAN TO REQUEST SIMILAR RULINGS BY OTHER REGULATORY AUTHORITIES WORLDWIDE IN COMING DAYS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

BRIEF-BioNTech Says Pfizer,Co Request Regulatory Agencies Expand Emergency Use Of Their Covid-19 Vaccine To Adolescents

Risk Disclaimer